Georgia's Online Cancer Information Center

Breast & Ovarian Cancer Screening Tool Score Interpretation

This score interpretation is for the breast and ovarian cancer genetics referral screening tool provided by Georgia CORE. Our tool utlizes the questions and algorithms provided by the Ontario Family History Assessment Tool.


Person has a 5-10% or greater chance of carrying a mutation in BRCA1 or BRCA2, which are associated with substantially increased risks (10 fold or more) for early onset breast cancer and ovarian cancer. Referral for cancer genetic counseling is indicated.

Note: Individuals who screen positive on this screening may not be found to be appropriate candidates for BRCA1/2 testing when a comprehensive cancer risk assessment is performed.


Person is unlikely to carry a BRCA1/2 mutation. Based on family history, person's risks for breast/ovarian cancer expected to be at or below that of the general population.

Note: For situations in which persons do not have a family history suggestive of hereditary cancer, but clinical considerations suggest additional education would be beneficial, risk assessment and/or enhanced screening or prevention strategies may be appropriate for some of these individuals.


  • This screening tool does not assess non-familial risk factors for breast or ovarian cancer.
  • Changes in family history could result in a change in the risk score. This screening should be re-run if additional cases of breast and/or ovarian cancer occur.
  • In families with few females, single cases of ovarian cancer or early breast cancer may be related to a BRCA1/2 mutation.
  • There are other, less common hereditary causes of breast and ovarian cancer. A cancer genetics consultation should be pursued if:
    • There are multiple individuals with cancer in multiple generations
    • Cancers are of an usually early age of onset
    • Rare or unusual cancers or tumors have occurred (examples: cancer of adrenal glands, medullary thyroid cancer, hamartomatous polyps, paragangliomas)

Additional guidelines concerning multi gene panel testing and management

National Comprehensive Cancer Network (2019): Genetic/Familial High Risk Assessment: Breast, Ovarian and Pancreatic

National Comprehensive Cancer Network (2019): Genetic/Familial High Risk Assessment: Colorectal

Last Updated: 8/24/2020 12:00:00 AM

For Healthcare Providers

Screening & Genetics

Does cancer run in your family?

Knowing your family history can protect you.


If you're 40, it's time to start mammograms, according to new guidelines

New draft recommendations from the U.S. Preventive Services Task Force urges all women to get screened every other year, starting at age 40.


Colorectal cancer is rising among Gen X, Y & Z. Here are 5 ways to protect yourself

"Colorectal cancer is rapidly shifting to diagnosis at a younger age," conclude the authors of an American Cancer Society report released this month.


Looking Across Disciplines to Share the Breadth of Innovation in Cancer Care

On July 25, 2023, The American Journal of Managed Care® brought its Institute for Value-Based Medicine (IVBM) series to Atlanta, Georgia, where nnovation was on the agenda.


DNA sequencing can lead to longer, better lives for cancer patients. But why do so few get it?

Guidelines now call for everyone diagnosed with advanced lung and colon cancer to get their tumor genetically sequenced, and increasingly, patients with earlier stage disease, as well.


Georgia CORE releases report from Disparities in Cancer Clinical Trials Summit

On Sept. 30, Georgia's cancer experts shared advice and experiences with oncology providers, patient navigators and research managers - all to provide new ways to diversify participation in clinical trials. In February 2023, Georgia CORE issued a report with a recap and actions steps. Download the report >>


Georgia CORE


Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.